KYNB Kyntra Bio, Inc.

NASDAQ
$1.56

Kyntra Bio, Inc. (KYNB) Earnings News

Earnings press releases, previews and reviews for Kyntra Bio, Inc. (KYNB), newest first. Our most recent is review: Kyntra Bio Beats on a Normalized Loss, but FG-3246 Failure Leaves an Unfunded Single-Asset Roxadustat Bet.